{"database": "openregs", "table": "federal_register", "rows": [["2022-23033", "Nonprescription Drug Product With an Additional Condition for Nonprescription Use; Extension of Comment Period", "Proposed Rule", "The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule that appeared in the Federal Register of June 28, 2022. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.", "2022-10-24", 2022, 10, "https://www.federalregister.gov/documents/2022/10/24/2022-23033/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use-extension-of", "https://www.govinfo.gov/content/pkg/FR-2022-10-24/pdf/2022-23033.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule that appeared in the Federal Register of June 28, 2022. The Agency is taking this action in response to requests for an extension to allow...", "0910-AH62"]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2022-23033"], "units": {}, "query_ms": 0.5837789503857493, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}